Lixte Biotechnology Statistics Share Statistics Lixte Biotechnology has 4.56M
shares outstanding. The number of shares has increased by 19.33%
in one year.
Shares Outstanding 4.56M Shares Change (YoY) 19.33% Shares Change (QoQ) 0% Owned by Institutions (%) 1.49% Shares Floating 3.54M Failed to Deliver (FTD) Shares 14,034 FTD / Avg. Volume 0.66%
Short Selling Information The latest short interest is 44.36K, so 0.97% of the outstanding
shares have been sold short.
Short Interest 44.36K Short % of Shares Out 0.97% Short % of Float 0.98% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.27 and the forward
PE ratio is null.
Lixte Biotechnology's PEG ratio is
0.03.
PE Ratio -1.27 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 5.52 P/FCF Ratio -1.44 PEG Ratio 0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Lixte Biotechnology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.26,
with a Debt / Equity ratio of 0.
Current Ratio 3.26 Quick Ratio 3.26 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.79M Employee Count 2 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 156.99% in the
last 52 weeks. The beta is 0.48, so Lixte Biotechnology's
price volatility has been higher than the market average.
Beta 0.48 52-Week Price Change 156.99% 50-Day Moving Average 3.89 200-Day Moving Average 2.16 Relative Strength Index (RSI) 62.7 Average Volume (20 Days) 2,125,943
Income Statement
Revenue n/a Gross Profit n/a Operating Income -3.57M Net Income -3.59M EBITDA -3.57M EBIT -3.59M Earnings Per Share (EPS) -1.59
Full Income Statement Balance Sheet The company has 1.04M in cash and 0 in
debt, giving a net cash position of 1.04M.
Cash & Cash Equivalents 1.04M Total Debt n/a Net Cash n/a Retained Earnings -52.07M Total Assets 1.19M Working Capital 452.63K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -3.16M
and capital expenditures 0, giving a free cash flow of -3.16M.
Operating Cash Flow -3.16M Capital Expenditures n/a Free Cash Flow -3.16M FCF Per Share -1.41
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields LIXT does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for LIXT.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 5, 2023. It was a
backward
split with a ratio of 1:10.
Last Split Date Jun 5, 2023 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -57.63 Piotroski F-Score 1
